Results 11 to 20 of about 60,311 (178)

MERS-CoV Confirmation among 6,873 suspected persons and relevant Epidemiologic and Clinical Features, Saudi Arabia — 2014 to 2019

EClinicalMedicine, 2021
Background: Of the three lethal coronaviruses, in addition to the ongoing pandemic-causing SARS-CoV 2, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) remains in circulation. Information on MERS-CoV has relied on small sample of patients.
Andrew Maher, Shahul H Ebrahim
exaly   +3 more sources

On-site detection of MERS-CoV infections in a camel slaughterhouse in Kenya using a commercial rapid antigen test. [PDF]

Front Vet Sci
BackgroundMiddle East respiratory syndrome coronavirus (MERS-CoV) poses a significant public health risk, with dromedary camels being the primary reservoir hosts.
Ogoti BM, Riitho V, Rodon J, Mutono N, Tesch J, Oyugi J, Mureithi MW, Corman VM, Drosten C, Wildemann J, Thumbi SM, Müller MA.   +11 more
europepmc   +2 more sources

Development of Small-Molecule MERS-CoV Inhibitors

Viruses, 2018
Middle East respiratory syndrome coronavirus (MERS-CoV) with potential to cause global pandemics remains a threat to the public health, security, and economy. In this review, we focus on advances in the research and development of small-molecule MERS-CoV
Fei Yu, Jiang Shibo, Naru Zhang
exaly   +3 more sources

Colostrum from MERS-CoV seropositive camels for MERS prophylaxis and SARS-CoV-2 infection, a placebo controlled randomized trial. [PDF]

Sci Rep
COVID-19 pandemic is currently relatively controlled, mainly due to effective vaccines. Preparedness for future outbreaks should include means for reducing transmission of SARS-CoV-2 and other coronaviruses like MERS-CoV.
Masika H, Cherniak M, Britan-Rosich Y, Oster Y, Grupel D, Nama A, Nissan B, Planer D, Strahilevitz J, Israeli E, Kumari S, Mor O, Kirillov S, Alter J, Dessau M, Fahoum J, Cohen-Kfir E, Golan M, Wiener R, David D, Amer R, Rouvinski A, Elinav H.   +22 more
europepmc   +2 more sources

Immunogenicity and protective efficacy of MERS CoV, NL140422, and HKU4 spike protein nanoparticle vaccines. [PDF]

Npj Viruses
While vaccines against Middle East respiratory syndrome coronavirus (MERS-CoV) have had substantial preclinical and clinical development, few vaccine candidates target other related viruses with potential for human spillover within the Merbecovirus ...
Halfmann PJ, Lee JS, Wang T, Duffy A, Kawaoka Y, Kane RS.   +5 more
europepmc   +2 more sources

MERS-CoV [PDF]

, 2019
Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic coronavirus. First identified in 2012, MERS-CoV has caused over 2460 infections and a fatality rate of about 35% in humans. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV), MERS-CoV likely originated from bats; however, different from SARS-CoV, which ...
Du, Lanying, Li, Fang
  +6 more sources

Impact of MERS-CoV and SARS-CoV-2 Viral Infection on Immunoglobulin-IgG Cross-Reactivity

Vaccines, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a considerable threat to public health and global economies. SARS-CoV-2 has largely affected a vast world population and was declared a COVID-19 pandemic outbreak, with a substantial ...
Joud Mohammed AlKhalifah, Waleed Seddiq, Mohammed Abdullah Alshehri, Abdulkarim Alhetheel, Ahmed Albarrag, Sultan Ayoub Meo, Jaffar A. Al-Tawfiq, Mazin Barry   +7 more
doaj   +1 more source

Evaluation of a Rapid Immunochromatographic Middle East Respiratory Syndrome Coronavirus Antigen Detection Assay

Infectious Microbes & Diseases, 2022
. Middle East respiratory syndrome coronavirus (MERS-CoV) infection in humans has a high mortality of >30%. Dromedaries are the reservoir of MERS-CoV and the main source of human infections.
Susanna Kar-Pui Lau, Kenneth Sze-Ming Li, Jade Lee-Lee Teng, Sunitha Joseph, Hayes Kam-Hei Luk, Joshua Fung, Ulrich Wernery, Patrick Chiu-Yat Woo   +7 more
doaj   +1 more source

Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization

Frontiers in Immunology, 2023
IntroductionThe Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a zoonotic infectious virus that has caused significant outbreaks in the Middle East and beyond.
Jeein Oh, Uni Park, Juhyung Kim, Kyeongseok Jeon, Kyeongseok Jeon, Chulwoo Kim, Nam-Hyuk Cho, Nam-Hyuk Cho, Nam-Hyuk Cho, Youn Soo Choi, Youn Soo Choi, Youn Soo Choi   +11 more
doaj   +1 more source

Liposome-Mediated Delivery of MERS Antigen Induces Potent Humoral and Cell-Mediated Immune Response in Mice

Molecules, 2022
The advancements in the field of nanotechnology have provided a great platform for the development of effective antiviral vaccines. Liposome-mediated delivery of antigens has been shown to induce the antigen-specific stimulation of the humoral and cell ...
Masood Alam Khan, Ajamaluddin Malik, Mohammad A. Alzohairy, Abdulmohsen M. Alruwetei, Bader Y. Alhatlani, Osamah Al Rugaie, Arif Khan   +6 more
doaj   +1 more source